Breast Cancer Research Review, Issue 28

In this issue:

 Using clinical/pathological data + genomic data to predict recurrence
 Palbociclib + letrozole: patientreported QOL
 Targeting CD73 expression looks promising in TNBC
 A new immunotherapy approach successful in metastatic disease?
 Intrathecal trastuzumab for breast cancer with carcinomatous meningitis
 Tailored FEC vs standard BSA-based calculation
 TNBC managed through two centres in Western Sydney
 Survival after neoadjuvant trastuzumab or lapatinib in HER2+ disease
 Employment participation after treatment of early-stage disease
 Glucocorticoid receptor steroid sulfatase impacts on clinical outcomes
 

Please login below to download this issue (PDF)

Subscribe